StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · MMED·Healthcare

MiniMed Group, Inc. Common Stock Stock Analysis & AI Score

MiniMed Group, Inc. Common Stock (MMED) has an ST Score of 62.3 (B), driven by its Momentum (A+) and held back by its Financial Strength (C). Analysts rate it Buy with a $25.88 price target (+26.6% upside).

Market Closed
$20.44
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
62
ST Score
62.3/100B

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Equipment & Services
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

MMED
62.3out of 100
Grade B

MiniMed Group, Inc. Common Stock (MMED) has an ST Score of 62.3 (B), driven by its Momentum (A+) and held back by its Financial Strength (C). Analysts rate it Buy with a $25.88 price target (+26.6% upside).

Strongest
MomentumA+
Weakest
Financial StrengthC
All factor grades
  • MomentumA+
  • ProfitabilityA
  • GrowthB
  • ValuationB-
  • ForecastB-
  • Financial StrengthC
  • Piotroski3/9
Score methodology
Press Releases

Contact

MMED stock: frequently asked questions

What is MMED's ST Score?

MiniMed Group, Inc. Common Stock (MMED) has an ST Score of 62.3 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is MMED a buy, hold, or sell?

Analysts rate MMED a Buy, with a price target of $25.88 (+26.6% vs the current price). Our ST Score grades it B (62.3/100). The ST Score is a data-driven signal, not a recommendation.

What are MMED's factor grades?

Valuation B-, Profitability A, Financial Strength C, Momentum A+, Growth B, Forecast B-.

What is MMED's valuation grade?

MiniMed Group, Inc. Common Stock (MMED) earns a valuation grade of B-, measured against Medical - Equipment & Services peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is MMED's growth grade?

MiniMed Group, Inc. Common Stock (MMED) earns a growth grade of B, measured against Medical - Equipment & Services peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is MMED's profitability grade?

MiniMed Group, Inc. Common Stock (MMED) earns a profitability grade of A, measured against Medical - Equipment & Services peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is MMED's financial strength grade?

MiniMed Group, Inc. Common Stock (MMED) earns a financial strength grade of C, measured against Medical - Equipment & Services peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for MMED?

The average analyst price target for MiniMed Group, Inc. Common Stock (MMED) is $25.88 from 8 analysts, which is +26.6% versus the recent price of $20.44.

What is MMED's Piotroski score?

MiniMed Group, Inc. Common Stock (MMED) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.